ICN Pharmaceuticals, U of Michigan to Study Lasers for Skin Diseases

ANN ARBOR, Mich., May 24 -- The University of Michigan has received funding from ICN Pharmaceuticals Inc. for a three-year study examining the medical benefits of non-ablative lasers. ICN currently markets two non-ablative lasers, NLite System and Cool Touch, to treat facial wrinkles.

Non-ablative lasers "could represent a new paradigm in the treatment of photoaging problems and skin diseases -- a non-invasive, relatively pain-free, effective treatment for a range of issues that were seen, not so long ago, as very difficult to treat," said John Voorhees, chair and professor of dermatology in the University of Michigan Medical School.